Saudi Enaya Cooperative Insurance Co. announces to Invites its Shareholders to Attend the ( First Meeting ) Ordinary General Assembly Meeting
|Introduction||The Board of Directors of Saudi Enaya Cooperative Insurance Company is pleased to invite its shareholders to attend the Ordinary General Assembly meeting number 9 (the first meeting), which will be held on Thursday 20 Rajab 1442 AH corresponding to 04 March, 2021AD, at exactly (06:30) through modern technology that enables shareholders to participate in its deliberations and voting on its decisions This is to insure the safety of Shareholders in the financial market and within the support of preventive and precautionary efforts and procedures taken by the competent and relevant health authorities to avoid the new Coronavirus (COVID-19), and as an extension of the continuous efforts made by all government authorities in the Kingdom of Saudi Arabia to take the necessary preventive procedures to prevent its spread|
|City and Location of the General Assembly's Meeting||Jeddah - Head Office Al-Rawda District, Though Tadawulaty|
|URL for the Meeting Location||www.tadawulaty.com.sa|
|Date of the General Assembly's Meeting||2021-03-04 Corresponding to 1442-07-20|
|Time of the General Assembly's Meeting||18:30|
|Attendance Eligibility||Shareholders Registered in the Issuer’s Shareholders Registry in the Depository Centre At the End of the Trading Session Preceding the General Assembly’s Meeting as per Laws and Regulations|
|Quorum for Convening the General Assembly's Meeting||The first Ordinary General meeting will be valid if attended by shareholders representing at least Quarter of the capital, and if the quorum required for holding this meeting is not meet, the second meeting will be held one hour after the end of the period specified for the first meeting, and the second meeting will be valid with any percent.|
|General Assembly Meeting Agenda||Item (1): Approval on the deception of the Board of Directors to appoint Mr. Hamad Abdulla Mohamed Almehyas Al Ali ( Member CV Attached), representative of the National Health Insurance Company - Daman as a non-executive member of the Board of Directors starting from the date of appointment on 29/04/1442 AH corresponding to 14/12/2021 AD to complete the session of the Board until the end of the current session on 07/03/2021 to replace the previous member Mr. Khaled Abdullah AImass non-executive member. |
Item (2): Approval on the deception of the Board of Directors to appoint Mr. Amr Mohamed K Khashoggi ( Member CV Attached), Independent Member of the Board of Directors starting from the date of appointment on 29/04/1442 AH corresponding to 14/12/2021 AD to complete the session of the Board until the end of the current session on 07/03/2021 to replace the previous member Dr. Mazen Suliman Fakee non-executive member.
Item (3): Voting on the election of members of the Board of Directors from among the candidates for the 4th term, which will start from 08/03/2021 and end on 07/01/2024
|E-Vote||We would like to point out that the Shareholders registered in Tadawulaty services will be able to vote remotely on the Assembly items starting from 10:00 am on Sunday, 28-02-2021 until the end of the time of the Assembly’s meeting. Contributors using the following link: www.tadawulaty.com.sa|
|Eligibility for Attendance Registration and Voting||Eligibility for Registering the Attendance of the General Assembly’s Meeting Ends upon the Convenience of the General Assembly’s Meeting. Eligibility for Voting on the Business of the Meeting Agenda Ends upon the Counting Committee Concludes Counting the Votes|
|Method of Communication||Any questions or quires should be communicated to shareholder relations on Invest@saudienaya.com |
or by calling 966125923653
The Capital Market Authority and the Saudi Stock Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.